Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-Metastatic, Post-Resection Pancreas Cancer

This study is currently recruiting participants.

Study NCT00300950 Information provided by GlobeImmune

First Received: March 8, 2006 Last Updated: April 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)